opendata.bot
Company number
12392992

GENOME THERAPEUTICS LTD

Active
✓ Active company on the official register. Next accounts due 31 March 2027.

Company details

London, England Contains OS data © Crown copyright and database right. Contains Royal Mail data © Royal Mail copyright and database right. Source: Office for National Statistics licensed under the Open Government Licence v.3.0.
Registered name
GENOME THERAPEUTICS LTD
Company number
12392992
Registered office
REGENT HOUSE, 316 BEULAH HILL, LONDON, SE19 3HF, UNITED KINGDOM · 176 other companies at this postcode
Company type
Private Limited Company
Incorporated on
8 January 2020
Status
Active
Age
6 years
Previous names
INFLEX LIMITED (to 15 Jun 2024)
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts — next due
31 Mar 2027
Accounts — last made up to
30 Jun 2025
Confirmation statement — next due
21 Jan 2027
Confirmation statement — last
07 Jan 2026

What the register says

Facts from the register, with the dates they are filed under. Not a score: what they mean is for you to judge, and every line can be checked against Companies House itself.

Companies House register snapshot, read 02/09/2026.

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Dr Bobby Satyadev Yerramilli-Rao
owns 25–50% of shares · holds 25–50% of voting rights
Notified 08/01/2020
Dr Samuel Aparicio
owns 25–50% of shares · holds 25–50% of voting rights
Notified 25/01/2025
Dr Samuel Aparicio
owns 25–50% of shares · holds 25–50% of voting rights
Notified 22/04/2022
Prof Sir Shankar Balasubramanian
owns 25–50% of shares · holds 25–50% of voting rights
Notified 08/01/2020

Corporate structure

Who controls this company, and who they control in turn

4 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Dr Bobby Satyadev Yerramilli-Rao
born 05/1966 · United Kingdom owns 25–50% of shares · holds 25–50% of votes Control ended 29/01/2020 Controls 5 companies
Dr Samuel Aparicio
born 10/1963 · Canada owns 25–50% of shares · holds 25–50% of votes Control ended 08/08/2025 Controls 2 companies
Dr Samuel Aparicio
born 10/1963 · Canada owns 25–50% of shares · holds 25–50% of votes Control ended 18/10/2024 Controls 2 companies
Prof Sir Shankar Balasubramanian
born 09/1966 · England owns 25–50% of shares · holds 25–50% of votes Control ended 08/08/2025 Controls 3 companies

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
08/08/2025 Person with significant control ceased Prof Sir Shankar Balasubramanian
08/08/2025 Person with significant control ceased Dr Samuel Aparicio
25/01/2025 Person with significant control added Dr Samuel Aparicio
18/10/2024 Person with significant control ceased Dr Samuel Aparicio
15/06/2024 Registered name changed INFLEX LIMITED GENOME THERAPEUTICS LTD
22/04/2022 Person with significant control added Dr Samuel Aparicio
29/01/2020 Person with significant control ceased Dr Bobby Satyadev Yerramilli-Rao
08/01/2020 Person with significant control added Prof Sir Shankar Balasubramanian
08/01/2020 Person with significant control added Dr Bobby Satyadev Yerramilli-Rao

Financial highlights

Parsed from the filed statutory accounts (£ thousands, except employees)

Source: Companies House bulk data filed accounts (iXBRL)
Metric FY2025FY2024
Total assets less current liabilities 365
▼ 78.6%
1,707
Net assets 365
▼ 78.6%
1,707
Employees (avg) 6 6

Documents for GENOME THERAPEUTICS LTD

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

Registered with the Information Commissioner's Office as a data protection fee payer.

Genome Therapeutics Ltd — SE19 3HF
Tier 1 · renews 27/06/2027
ICO entry

The ICO publishes no company number, so this is matched on the registered name and confirmed by the postcode. Check the ICO entry before relying on it.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/12392992
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of GENOME THERAPEUTICS LTD?
According to the official registry, the company number of GENOME THERAPEUTICS LTD is 12392992.
Where is GENOME THERAPEUTICS LTD registered?
The registered office is REGENT HOUSE, 316 BEULAH HILL, LONDON, SE19 3HF, UNITED KINGDOM.
What is the SIC code of GENOME THERAPEUTICS LTD?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology.
Who controls GENOME THERAPEUTICS LTD?
Dr Bobby Satyadev Yerramilli-Rao is recorded as a person with significant control, and owns 25–50% of shares, holds 25–50% of voting rights.
When are the next accounts of GENOME THERAPEUTICS LTD due?
The next annual accounts are due by 31 March 2027, and the last accounts were made up to 30 June 2025.

About GENOME THERAPEUTICS LTD (12392992)

GENOME THERAPEUTICS LTD is a private limited company incorporated on 8 January 2020 and registered in the United Kingdom under company number 12392992. Its registered office is at REGENT HOUSE, 316 BEULAH HILL, LONDON, SE19 3HF, UNITED KINGDOM. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently active , with statutory accounts last made up to 30 June 2025. , and the person with significant control is Dr Bobby Satyadev Yerramilli-Rao. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.